Motilin receptor density in inflamed and noninflamed tissue in rabbit TNBS-induced colitis

Neurogastroenterology and Motility

Volumn 13, Issue 1, 2001, Pages 55-63

  Depoortere, I ^a   Van Assche, G ^a   Peeters, T L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Contractility; Motilin mRNA expression; Motilin receptor density; Mucosal motilin content; TNBS

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN RECEPTOR; MESSENGER RNA; MOTILIN; MOTILIN RECEPTOR; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; COLITIS; COLON; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DUODENUM; FEMALE; HORMONAL REGULATION; INFLAMMATION; JEJUNUM; MALE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RABBIT; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

ANIMALS; AUTORADIOGRAPHY; COLITIS; FEMALE; INTERLEUKIN-1; INTESTINAL MUCOSA; MALE; MUSCLE CONTRACTION; PEROXIDASE; RABBITS; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, INTERLEUKIN-1; RECEPTORS, NEUROPEPTIDE; TRINITROBENZENESULFONIC ACID;

EID: 0035114196     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2982.2001.00240.x     Document Type: Article

References (43)

1. Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy
2. Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis
3. Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease
4. Distribution and quantification of gut neuropeptides in normal intestine and in inflammatory bowel disease
5. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease
6. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease
7. Peptide-containing nerve fibers in the gut wall in Crohn's disease
8. Colonic vasoactive intestinal polypeptide in ulcerative colitis
9. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis - A radioimmunoassay and immunohistochemical study
10. Somatostatin in the idiopathic inflammatory bowel diseases
11. Distribution and quantification of somatostatin in inflammatory disease
12. Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease
13. Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease
14. Receptors for sensory neuropeptides in human inflammatory diseases: Implications for the effector role of sensory neurons
15. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease
16. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis
17. Evidence for mast cell, leukotriene and nitric oxide involvement in the regulation of the adrenoreceptor number of inflamed small intestine in guinea pigs
18. Inverse regulation of alpha and beta-adrenoreceptors during TNB-induced inflammation in guinea pig small intestine
19. Altered calcium-handling properties of jejunal smooth muscle from the nematode-infected rat
20. Altered smooth muscle contraction and sodium pump activity in the inflamed rat intestine
21. --induced contractility in rabbits
22. Effect of erythromycin and of octreotide on motilin receptor density in the rabbit
23. Gut hormones in inflammatory bowel disease
24. Gut hormone responses after reconstructive surgery for ulcerative colitis
25. Distribution and subcellular localization of motilin binding sites in the rabbit brain
26. In vitro changes in the properties of rabbit colonic muscularis mucosae in colitis
27. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
28. Motilin receptors in rabbit stomach and small intestine
29. A simple method for the determination of affinity and binding site concentration in receptor binding studies
30. Protein measurements with folin phenol reagent
31. In man, only activity fronts that originate in the stomach correlate with motilin peaks
32. The isolation and characterization of rabbit motilin precursor cDNA
33. Cloning and sequence analysis of a cDNA for lymphocyte proliferation potentiating factor of rabbit polymorphonuclear leukocytes: Identification as rabbit interleukin 1β
34. Interleukin-1 receptor antagonist in inflammatory exudate cells of rabbits. Production, purification and determination of primary structure
35. Sequence of the rabbit glyceraldehyde-3-phosphate dehydrogenase-encoding cDNA
36. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
37. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification
38. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in the rabbit immune colitis
39. Dose-dependent effects of interleukin-11 on contractile parameters in rabbit TNBS-colitis
40. Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed
41. Delayed gastric emptying in children with Crohn's disease
42. Gastric emptying in childhood inflammatory bowel disease: Nutritional and pathologic correlates
43. Characterization of suppression of food intake following acute colonic inflammation in the rat